Today's Healthcare Pulse
Allogene Therapeutics CEO David Chang to step down
Allogene Therapeutics announced that chief executive David Chang will leave his role. The news was reported by STAT+ and echoed in a follow‑up piece covering broader pharma updates.
Also developing:
By the numbers: Boston Scientific invests $1.5B for 34% stake in MiRus
Protect Yourself From Rising Medicare Fraud
Medicare beneficiaries face escalating fraud schemes as the Financial Crimes Enforcement Network (FinCEN) issues a new advisory urging vigilance. Expert Jae Oh stresses that fraud typically starts with stolen personal data, making beneficiaries the first line of defense. He recommends verifying insurance agents' National Producer Numbers, reviewing Medicare Summary Notices for unauthorized charges, and safeguarding Medicare IDs. The interview also highlights the supportive role of financial advisers and family caregivers in preventing scams.
Phone Follow-Ups Smoothe Transitions Home
A Fraser Health study of more than 7,000 high‑risk patients found that nurse‑led telephone follow‑ups 48 hours after discharge reduced short‑term emergency department visits. The intervention lowered 7‑day ED returns by roughly 28% and 30‑day returns by 12% after adjusting...
Quebec Drops Many ER Stats From Public Dashboard
Since Santé Québec assumed control of Quebec's health‑care dashboard in February, it has stripped away most emergency‑room (ER) performance targets and key overcrowding indicators that were previously public. The removal eliminates visual cues such as the red‑dotted line that showed...
Virtual ERs Working for Rural Alberta: Study
Alberta Health Services' Virtual Emergency Physician (VEP) program, launched in early 2025, connects off‑site emergency doctors with rural emergency departments lacking on‑site coverage. In the first six months, virtual physicians covered 229 shifts (about 3,000 hours), treated roughly 1,150 low‑acuity...
Donors Provide $5.75M to Cross-Sector Think-Tank
McGill University has launched the Initiative for Transforming Healthcare (ITH), a cross‑sector think‑tank aimed at tackling Canada’s mounting health‑system pressures. The effort unites the Desautels Faculty of Management, the Faculty of Medicine and Health Sciences, and the Max Bell School...
Abu Dhabi AI Hub Unveils Lifespan Health Data Platform, Boosting Early Disease Detection
On World Health Day 2026, the Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) launched a new AI platform that fuses brain imaging, genomic and clinical data to predict Alzheimer’s up to 20 years early. The system, part of a...
Medvi’s $1.8B Telehealth Surge Stalls Over AI‑Generated Doctor Ads
Medvi, an AI‑driven telehealth firm that posted $401 million in revenue last year and expects $1.8 billion this year, is being investigated after affiliate marketers ran ads featuring AI‑generated doctors. Regulators and consumer groups say the practice breaches FTC rules and misleads...
FirstHX Offers Ambient Scribe that Doesn’t Guess
FirstHx Corp. launched ARIS, a next‑generation ambient scribe that injects clinician‑grade patient history into the AI workflow before the encounter begins. By gathering structured data from patients ahead of time, ARIS provides the contextual foundation that eliminates the hallucinations typical...
Engineered Immunosuppressive Dendritic Cells Protect Against Cardiac Remodelling
Researchers engineered fibroblast‑activation‑protein (FAP)‑targeted immunosuppressive dendritic cells (iCDCs) that co‑express CTLA4‑Ig, PD‑L1 and IL‑10. In mouse myocardial infarction, ischemia‑reperfusion and pressure‑overload models, a single iCDC infusion markedly improved ejection fraction, reduced ventricular dilation and fibrosis, and extended survival. The therapy...
What to Watch: FDA's FY 2027 Budget
The FDA’s FY 2027 budget, a $7.2 billion request, outlines several policy‑driven proposals. It seeks new statutory authority to label misleading direct‑to‑consumer drug ads as misbranded, and introduces an optional “Expedited IND” pathway to accelerate Phase 1 trials using validated pre‑clinical data. The...
Novo Nordisk's Explosive Wegovy Pill Launch Draws a New Wave of Patients Into GLP-1 Weight Loss Treatment
Novo Nordisk’s oral Wegovy pill launched in January and has already generated over 600,000 prescriptions within three months, attracting tens of thousands of new patients who previously avoided GLP‑1 injections. The drug is priced at $149‑$299 per month, markedly lower...
Turmeric‑Ginger Coating Doubles Bone Bonding, Cuts Bacteria, Cancer Cells
Turmeric and ginger extract applied to titanium implants can double bone bonding in six weeks, eliminate 92% of surface bacteria, and sharply reduce cancer-causing cells, offering a promising advance for joint replacement and bone cancer patients. biomaterials
University of Arizona Launches $12 Million Rapamycin Clinical Trial
The University of Arizona’s R. Ken Coit College of Pharmacy is launching a double‑blind, randomized Phase 3 clinical trial to test low‑dose rapamycin’s ability to boost resilience and immune function in adults aged 65 and older. The six‑year study, funded by a...
FinCEN Advisory Mandates Expansion of SAR Reporting in Healthcare Context
FinCEN issued a March 30, 2026 Healthcare Fraud Advisory (FIN‑2026‑A001) that adds 24 new, healthcare‑specific red flags for banks to monitor. The guidance targets three core fraud schemes: shell companies posing as providers, false or inflated Medicare/Medicaid claims, and laundering of illicit...
Court Orders FDA To Provide Update On Mifepristone Review Before Midterms
A Louisiana district judge ordered the FDA to issue an update on its Risk Evaluation and Mitigation Strategy (REMS) review for the abortion medication mifepristone within six months. The mandate arrives as the Trump administration faces pressure to clarify its...
Nursing Homes, Providers Mixed Over Proposed 2.4% Bump In Fiscal 2027 Pay
The Centers for Medicare & Medicaid Services (CMS) has proposed a 2.4% increase in Medicare reimbursement rates for skilled nursing facilities (SNFs) for fiscal year 2027. The nursing‑home lobby praised the move as a practical boost to Medicare payments, while...
![Why Loving Organizations Are the Secret to Ending Burnout in Medicine [PODCAST]](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://kevinmd.com/wp-content/uploads/603e9e41-66d6-47f3-a831-f1f9c17489b3.jpeg)
Why Loving Organizations Are the Secret to Ending Burnout in Medicine [PODCAST]
Physician coach Dr. Apurv Gupta discussed his "loving organization" framework on the KevinMD podcast, highlighting how 19 health‑care exemplars use the INTEGRATE model to embed love into leadership, teams, processes and technology. He explained that these organizations achieve lower burnout,...
Chocolate Recalled because It Contains Erectile Dysfunction Drug
Nalpac is voluntarily recalling its DTF Sexual Chocolate after testing revealed the presence of sildenafil and tadalafil, the active ingredients in Viagra and Cialis. The undeclared erectile‑dysfunction drugs were found in 20‑unit cases sold through adult‑focused retailers and two online...
Q&A: The Slack Channels Powering CMS' Interoperability Framework
The Centers for Medicare & Medicaid Services (CMS) has launched an Interoperability Framework that relies on public Slack channels to bring together a broad coalition of health‑tech firms, consultants, and government agencies. By inviting any interested party to join as...
What Are the Health Impacts of Sea-Level Rise, and Who Should Pay?
The Lancet Commission on sea‑level rise health and justice was launched to examine how rising oceans threaten Pacific health systems, with 62% of facilities within 500 metres of the coast. Experts warn that saltwater intrusion, water‑borne disease, displacement and food insecurity...
![[Comment] Life at the Water's Edge: A Lancet Commission on Sea-Level Rise, Health, and Justice](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/f7b862f66dee1270bd326b6a9b7e8859.webp)
[Comment] Life at the Water's Edge: A Lancet Commission on Sea-Level Rise, Health, and Justice
The Lancet Commission’s latest comment warns that accelerating sea‑level rise will reshape daily life for hundreds of millions, with up to 410 million people projected to live below the high‑tide line by 2100. It details how rising waters amplify disease transmission,...
The Doctor Who Proved Handwashing Saves Lives Was Locked in an Asylum for It
In 1847 Ignaz Semmelweis, a physician at Vienna General Hospital, introduced mandatory handwashing in a chlorinated lime solution, slashing maternity ward mortality from 18% to 2%. His data‑driven approach proved that physicians were transmitting fatal infections to patients. The medical...
Low-Field MRI Revolutionizes Global Dementia Care
Low‑field MRI scanners, priced under $100,000 and free of cryogenic cooling, are emerging as affordable, portable alternatives to traditional high‑field systems. Clinical studies across multiple continents demonstrate 85% sensitivity for early‑stage dementia markers such as hippocampal atrophy. The technology enables...
Misdiagnosed PCOS Can Worsen Hypothalamic Amenorrhea
Eight doctors told me I had PCOS. I had hypothalamic amenorrhea. The symptoms overlap but the treatment is opposite. PCOS is often treated with carb restriction and blood sugar regulation (often metformin). HA is treated by eating more and...
Shingles Vaccine Beats Geroscience in Reducing Dementia
a different take: the shingles vaccine lowers dementia and all cause mortality and it’s targeted to a specific virus, not the process of aging so far the data say the score is shingles vaccine 1, geroscience hypothesis 0 and I could say the...
Scientists Achieve Major Breakthrough in Safe, Reversible Male Contraception
A multinational research team announced a breakthrough in male contraception: a non‑hormonal, reversible pill that achieved 95% efficacy in Phase‑III trials. The compound, which temporarily blocks sperm maturation, proved safe across a diverse cohort with no reported hormonal side effects....
Weight‑loss Drugs Boost Life by Aiding Sick, Not Slowing Aging
Weight loss drugs may increase human longevity but that's because they reduce the mortality of folks at the lower end of the lifespan distribution (i.e., unhealthy individuals), not because they delay the aging process. That's still valuable, but if this is...
Hair‑Loss Pill Redefines Masculinity and Aging
The Hair-Loss Drug Rewriting the Rules of Masculinity A pill to cure baldness is changing the way men age — and how they see themselves. https://t.co/4OiLpmOwGR https://t.co/YQLBx61gVT
Attendees Value Networking Opportunities at HIMSS26
HIMSS26’s TV floor interviews reveal that attendees consider networking the event’s biggest draw. Health‑IT professionals cite meeting peers, vendors, and former collaborators as a core reason for attending. The conference’s large, diverse audience creates fertile ground for both new connections...
New Cytotoxic Targets Unveiled at AACR26
Time to head off the beaten track at #AACR26 with our latest preview exploring novel targets and cytotoxics. The long climb up the hill may be worth it for some of them: https://t.co/l9tkdWvpuF https://t.co/M5B3RTW1wf
'Incredibly Worrisome': Concerns for Sick Refugees without Medicare
A growing number of asylum seekers in Australia are denied Medicare, leaving them without essential preventive care. Visa categories such as bridging visas often exclude families, and eligibility can lapse during lengthy residency processing. The story of Raj, who cannot...
Same Services, Sicker Individuals, Less Time: Daily Frustrations with Medicare Advantage as Acuity Rises in Nursing Homes
Medicare Advantage plans are forcing nursing homes to deliver the same level of care to sicker residents in dramatically shorter stays, compressing average skilled‑nursing episodes from about 21 days to as little as 7‑14 days. Methodist Retirement Communities (MRC) reports...
Proposed Federal Budget Includes Major Cuts to Healthcare Funding
The Trump administration’s 2027 budget proposal, released on April 3, calls for sweeping cuts to federal health programs, including a $5 billion reduction for the National Institutes of Health and a $129 million cut to the Agency for Healthcare Research and Quality. Overall,...
Trends in Manufacturer Coupons for Biologics: Decline in Use Despite Higher Per-Claim Value
Manufacturer-sponsored coupons for biologics have declined from 18.0% of patients in 2017 to 13.9% in 2024, even as the median coupon amount per claim rose from $60 to $90. The drop is most pronounced for obesity and diabetes therapies, while...
Q&A: Obesity Medicine 2026 Will Emphasize ‘Treating the Whole Picture’
The Obesity Medicine Association’s annual conference will take place April 10‑12 in San Diego, centered on the theme “The Heart of Obesity Care.” The event highlights a holistic view of cardiometabolic health, linking heart disease, diabetes, liver disease, and other...
Long-Term Cardiac Amyloidosis Survival Benefits Seen in Extension Acoramidis Trial
The open‑label extension of the ATTRibute‑CM trial demonstrated that the transthyretin stabilizer acoramidis (Attruby) delivers sustained survival benefits out to 54 months in patients with cardiac amyloidosis. Participants who began acoramidis early and remained on therapy showed markedly lower all‑cause...
Leg Amputee Forced to Wait Two Months for Rehabilitation Services
Phillip Norris, a 66‑year‑old radio announcer from Inverell, NSW, underwent a leg amputation in December and spent two months navigating a fragmented rehabilitation pathway. After multiple hospital transfers and a 2,000‑km travel burden, he finally received a prosthetic leg at...
CMS to Host 7th Annual HL7 FHIR Connectathon in July
The Centers for Medicare & Medicaid Services (CMS) will host its seventh annual HL7 Fast Healthcare Interoperability Resources (FHIR) Connectathon from July 14‑16, 2026. The virtual event will bring together interoperability leaders, implementers and innovators to conduct hands‑on testing of...
Is Vitamin D Associated with Lower Levels of Alzheimer’s Biomarkers?
A longitudinal study of 793 adults tracked vitamin D levels at an average age of 39 and brain‑scan biomarkers 16 years later. Participants with serum vitamin D above 30 ng/mL showed significantly lower tau protein accumulation, a key Alzheimer’s marker, while no link...
Heart Attack, Stroke Risk Can Double From Irregular Bedtimes, Sleeping Less than 8 Hours
A Finnish cohort study of 3,231 middle‑aged adults found that people who keep irregular bedtimes and sleep fewer than eight hours a night face nearly double the risk of major cardiovascular events over the next decade. Researchers used a week...
Insmed Discontinues Development of Skin Condition Drug After Mid-Stage Study Miss
Insmed announced it will discontinue development of brensocatib, its investigational therapy for hidradenitis suppurativa, after the drug failed to meet the primary efficacy endpoint in a mid‑stage trial. The study aimed to reduce painful nodules in patients with the chronic...
Darwin Midwife's $1.1 Million Government Contract Under Review
The Northern Territory government is reviewing a $1.1 million contract granted to Claire Marks, a midwife whose registration is limited to supervised practice. The funding supports her firm Midwives in Darwin, created to plug a void after the collapse of private...
FDA Approves First Generic Dapagliflozin to Reduce HF Hospitalization Risk in Type 2 Diabetes
The FDA has approved the first generic dapagliflozin tablets, expanding access to the SGLT2 inhibitor that lowers heart‑failure hospitalizations in type‑2 diabetes. The generics match the branded product’s safety and efficacy profile, offering a lower‑cost alternative to Farxiga. This approval...
Hints of a Mortality Benefit With TTVR at 2 Years TRISCEND II
The TRISCEND II trial shows transcatheter tricuspid valve replacement (TTVR) remains safe and improves quality of life at two years. A post‑hoc crossover analysis suggests a mortality advantage for patients receiving the Edwards Evoque device versus those who never received TTVR. While...
CDC Finds Nearly Half of U.S. Adults Get Recommended Amount of Physical Activity
The CDC’s April 7 data brief reports that 47.2% of U.S. adults met the federal aerobic‑activity guideline in 2024, up from previous years. Men (52.3%) were more likely than women (42.4%) to achieve the target. Compliance rose with higher education,...
ASHE’s 2026 Health Care Facilities Innovation Conference Set for August
The American Society for Health Care Engineering (ASHE) announced that registration is now open for its 2026 Health Care Facilities Innovation Conference, scheduled for August 2‑5 in Minneapolis. The event, formerly known as the ASHE Annual Conference & Technical Exhibition, is...
Lifestyle Interventions as a Pillar of Breast Cancer Risk Reduction With Douglas Marks, MD
In a Managed Care Cast interview, NYU oncologist Douglas Marks highlighted how diet, regular exercise, and reduced alcohol intake can substantially lower a woman's risk of developing breast cancer. He cited robust epidemiologic data linking these lifestyle changes to measurable...
Jefferson Health Sues Aetna over Downcoding, Avoids Class Action
Jefferson Health sues Aetna over ‘downcoding’ policy I’m surprised they couldn’t make this a class action lawsuit https://t.co/tZgfdFxRJE
AlpE Combo: New Tuberculosis Treatment Breakthrough
An international research team has introduced AlpE, a novel combination of Alpibectir and ethionamide, that dramatically shortens tuberculosis therapy and boosts efficacy against drug‑resistant strains. Alpibectir, a new class of mycobacterial enzyme inhibitor, works synergistically with ethionamide to disrupt cell‑wall...
WHO Launches ‘Together for Health’ Campaign on World Health Day, Emphasizing Science‑Based Wellness
The World Health Organization kicked off a year‑long “Together for Health” campaign on 7 April 2026, positioning scientific collaboration as the engine for improved physical and mental well‑being. The initiative mobilizes governments, NGOs, and citizens worldwide to adopt evidence‑based health practices.